InfuSystem Holdings, Inc. Quarterly report [Sections 13 or 15(d)]

Revenue (Tables)

9 Months Ended

Sep. 30, 2025

The following table presents the Company’s disaggregated revenue by offering type (in thousands):


	Three Months Ended September 30,
	2025				2024
	Total Net Revenues		Percentage of Total Net Revenues		Total Net Revenues		Percentage of Total Net Revenues
Patient Services revenue recognized at a point in time:
Direct products	$	690	1.9	%	$	685	1.9	%
Third-Party Payer products	4,822		13.2	%	3,917		11.1	%
Patient Services revenue recognized over time:
Direct rental services	1,985		5.4	%	1,923		5.4	%
Third-Party Payer rental services	12,723		34.9	%	12,277		34.8	%
Total Patient Services accounted for under ASC 606	20,220		55.4	%	18,802		53.2	%
Device Solutions revenue recognized at a point in time:
Products	4,100		11.2	%	4,731		13.4	%
Services	3,379		9.3	%	2,575		7.3	%
Device Solutions revenue recognized over time:
Services	1,263		3.5	%	1,841		5.2	%
Total Device Solutions accounted for under ASC 606	8,742		24.0	%	9,147		25.9	%
Total Revenue Accounted for under ASC 606	28,962		79.4	%	27,949		79.1	%
Patient Services lease revenue	2,144		5.9	%	1,978		5.6	%
Device Solutions lease revenue	5,382		14.8	%	5,393		15.3	%
Total Revenue accounted for under ASC 842, Leases	7,526		20.6	%	7,371		20.9	%
Total Net Revenue	$	36,488	100.0	%	$	35,320	100.0	%


	Nine Months Ended September 30,
	2025				2024
	Total Net Revenues		Percentage of Total Net Revenues		Total Net Revenues		Percentage of Total Net Revenues
Patient Services revenue recognized at a point in time:
Direct products	$	1,979	1.8	%	$	2,030	2.0	%
Third-Party Payer products	12,880		12.0	%	11,182		11.1	%
Patient Services revenue recognized over time:
Direct rental services	5,834		5.4	%	5,724		5.7	%
Third-Party Payer rental services	37,522		35.0	%	35,144		34.8	%
Total Patient Services accounted for under ASC 606	58,215		54.3	%	54,080		53.5	%
Device Solutions revenue recognized at a point in time:
Products	12,567		11.7	%	12,886		12.8	%
Services	8,463		7.9	%	7,442		7.4	%
Device Solutions revenue recognized over time:
Services	4,866		4.5	%	5,850		5.8	%
Total Device Solutions accounted for under ASC 606	25,896		24.2	%	26,178		25.9	%
Total Revenue Accounted for under ASC 606	84,111		78.5	%	80,258		79.5	%
Patient Services Lease Revenue	6,438		6.0	%	5,537		5.5	%
Device Solutions Lease Revenue	16,657		15.5	%	15,218		15.1	%
Total Revenue accounted for under ASC 842, Leases	23,095		21.5	%	20,755		20.5	%
Total Net Revenue	$	107,206	100.0	%	$	101,013	100.0	%